Page results
-
Patient information for patients suffering from long COVID who are trying to return to physical activity,
-
A large trial at UCLH is looking to optimise chemotherapy for young people with nodular lymphocyte predominant Hodgkin lymphoma (NLPHL).
-
A new centre at UCLH launched today will work to ensure health research is accessible to everyone.
-
Nearly 200 people have visited a family-friendly open event in Islington which engaged the local community in the latest research and innovation in the NHS.
-
UCLH and UCL researchers and engineers are using artificial intelligence (AI) to make brain surgery safer and more effective.
-
A large trial at UCLH and UCL will investigate whether a drug currently in use to treat respiratory conditions can slow the progress of Parkinson’s disease.
-
A team at UCLH and UCL have developed new methods to predict outcomes for pregnancies where there are issues with poor growth of the baby inside the womb.
-
The comprehensive review, co-authored by UCLH Director of Research Prof Bryan Williams, recommends approaches including mindfulness practices and reducing exposure to air polluion.
-
A UCLH patient with a rare hormonal condition is the first in the world to receive a new investigational drug in a first-in-human trial.
-
Patient information for patients dealing with difficult feelings. This information will give you useful advice about what to do if you find yourself in a crisis.
File results
-
FOI/2023/0356 - Current wait time for referral to treatment with a consultant for osteoporosis
-
FOI/2023/0361 - List of all the doctors and consultants working within UCLH
-
FOI/2023/0363 - External management/ business consultants spend/ fees to recruitment agencies for 2023
-
FOI/2023/0368 - Apprenticeship Levy - 2019-20 to 2022/23 (Part 1)
-
FOI/2019/484 Homless patients admitted to ED
-
FOI/2019/411 ICT and Facilities contact details
-
FOI/2019/449 Specialist Stoke Unit at the Trust
-
FOI/2019/457 Invoiced income to non-EU overseas visitors
-
FOI/2019/468 Rheumatoid Arthritis biologic pathway
-
FOI/2019/516 TMS and SCS protocols, guidelines and treatment pathways